Coronavirus Live Count Map India
remove_red_eye 993 Views
COVID-19 Vaccine Updates
#Business And Medicine #Emergency Medicine #Infectious Diseases #Pathology and Lab Medicine #Pharmacist #Public Health #Pulmonary Medicine
Hyderabad: Bharat Biotech has entered into a licensing agreement with the Washington University School of Medicine in St Louis (WashU) for developing, conducting clinical trials, manufacturing and distributing a chimp-adenovirus, single dose intranasal vaccine candidate for COVID-19.
According to the deal, Bharat Biotech will distribute the vaccine in all global markets, excluding US, Europe and Japan. The Phase I trials for the vaccine will be conducted in Saint Louis University’s vaccine and treatment evaluation unit.The company will look after further clinical trials for the vaccine in India following approvals. Large scale manufacturing of the vaccine will be carried out at the company’s facility in Hyderabad. It plans to manufacture about a billion doses… (ET Healthworld – TNN, September 24, 2020)